zirconium has been researched along with Carcinoma, Non-Small Cell Lung in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Bahce, I; de Gruijl, TD; Elgadi, M; Grempler, R; Hesse, R; Huisman, MC; Menke-van der Houven van Oordt, CW; Miedema, IHC; Peltzer, A; Pitarch, AP; Thiele, A; van Dongen, GAMS; Vugts, DJ; Zwezerijnen, GJC | 1 |
de Vries, EGE; Giesen, D; Kol, A; Lub-de Hooge, MN; Pool, M; Terwisscha van Scheltinga, AGT | 1 |
Bensch, F; Boellaard, R; Bohorquez, SS; Brouwers, AH; de Crespigny, A; de Vries, EGE; Elias, SG; Fine, BM; Gietema, JA; Groen, HJM; Hiltermann, TJN; Jorritsma-Smit, A; Kok, IC; Kwee, TC; Lub-de Hooge, MN; Mancao, C; Oosting, SF; Schröder, CP; van der Veen, EL; van der Wekken, AJ; Williams, SP | 1 |
Li, K; Mallick, P; Marks, JD; Mumenthaler, SM; Tavaré, R; Wu, AM; Zettlitz, KA; Zhou, Y | 1 |
Andersson, KG; Garousi, J; Löfblom, J; Mitran, B; Orlova, A; Pichl, ML; Ståhl, S; Tolmachev, V | 1 |
de Jong, S; de Vries, EG; Gerdes, CA; Kol, A; Lub-de Hooge, MN; Pool, M; Terwisscha van Scheltinga, AG | 1 |
Boellaard, R; Snow, GB; Stigter-van Walsum, M; van Dongen, GA; Verel, I; Visser, GW | 1 |
1 trial(s) available for zirconium and Carcinoma, Non-Small Cell Lung
6 other study(ies) available for zirconium and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Head and Neck Neoplasms; Humans; Lung Neoplasms; Positron-Emission Tomography; Radioisotopes; Squamous Cell Carcinoma of Head and Neck; Zirconium | 2023 |
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Transformation, Neoplastic; Drug Resistance, Neoplasm; Erlotinib Hydrochloride; Feasibility Studies; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Lung Neoplasms; Male; Mice; Positron-Emission Tomography; Proto-Oncogene Proteins c-met; Radioisotopes; Resorcinols; Up-Regulation; Zirconium | 2017 |
Anti-MET immunoPET for non-small cell lung cancer using novel fully human antibody fragments.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Non-Small-Cell Lung; Cell Transformation, Neoplastic; Female; Heterografts; Humans; Immunoglobulin Fragments; Lung Neoplasms; Mice; Mice, SCID; Positron-Emission Tomography; Proto-Oncogene Proteins c-met; Radioisotopes; Radiopharmaceuticals; Zirconium | 2014 |
PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR:2377 affibody molecules.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; ErbB Receptors; Gene Expression Regulation, Neoplastic; Humans; Mice; Molecular Imaging; Positron-Emission Tomography; Xenograft Model Antitumor Assays; Zirconium | 2016 |
Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer 89Zr-imgatuzumab.
Topics: A549 Cells; Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; ErbB Receptors; Glycoproteins; Humans; Lung Neoplasms; Male; Mice, Nude; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Tissue Distribution; Transplantation, Heterologous; Zirconium | 2016 |
89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Non-Small-Cell Lung; Drug Stability; Feasibility Studies; Female; Humans; Isotope Labeling; Lung Neoplasms; Mice; Mice, Nude; Organ Specificity; Radioimmunodetection; Radioisotopes; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed; Zirconium | 2003 |